Telesis Bio develops and promotes the Gibson SOLA technology, a next-generation enzymatic synthesis platform.

Airna is a biotech company that specializes in RNA editing therapeutics, aiming to target diseases inaccessible through other methods, with its first program focusing on treating the inherited genetic disease alpha-1 antitrypsin deficiency (AATD).

BlueWhale Bio is a biotechnology company that specializes in overcoming bottlenecks in cell and gene therapy manufacturing.